Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17064889 | APPLIED TO A SKELETAL MINI ANCHORAGE SITE | October 2020 | March 2023 | Abandon | 30 | 1 | 0 | No | No |
| 17031133 | BARBED MESH FOR INCISION CLOSURE AND HERNIA REPAIR | September 2020 | April 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 17022577 | ROBOTIC CATARACT SURGERY USING FOCUSED ULTRASOUND | September 2020 | June 2024 | Allow | 45 | 3 | 0 | Yes | No |
| 17017056 | FAR BONE SUTURE BUTTON | September 2020 | April 2023 | Allow | 31 | 0 | 1 | Yes | No |
| 17016173 | ATHERECTOMY SYSTEM WITH ELECTROMAGNETIC GUIDEWIRE CLAMP | September 2020 | April 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 17010087 | SYSTEMS, SUTURE DEVICES, AND METHODS FOR TISSUE CLOSURE | September 2020 | April 2024 | Allow | 44 | 3 | 1 | Yes | No |
| 16994750 | FLEXIBLE CANNULA HAVING SELECTIVE RIGIDITY | August 2020 | March 2023 | Allow | 31 | 1 | 0 | Yes | No |
| 16936332 | Orthopedic Fixation Devices and Methods | July 2020 | July 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 16876330 | APPARATUS FOR TREATING GERD | May 2020 | January 2024 | Allow | 44 | 1 | 0 | No | No |
| 16635946 | IMPLANT FOR MEDICAL USE INTENDED TO CLIP TO A BIOLOGICAL PROTUBERANCE | January 2020 | January 2023 | Allow | 36 | 1 | 0 | No | No |
| 16347634 | VARIABLE RIGIDITY, CONFORMABLE APPARATUS FOR NON-INVASIVELY AFFIXING SURGICAL FIDUCIALS AND SURGICAL TOOLS TO PATIENTS | May 2019 | December 2023 | Allow | 56 | 1 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner BASET, NASHEHA works in Art Unit 3771 and has examined 11 patent applications in our dataset. With an allowance rate of 90.9%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner BASET, NASHEHA's allowance rate of 90.9% places them in the 75% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by BASET, NASHEHA receive 1.27 office actions before reaching final disposition. This places the examiner in the 15% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by BASET, NASHEHA is 36 months. This places the examiner in the 38% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +33.3% benefit to allowance rate for applications examined by BASET, NASHEHA. This interview benefit is in the 80% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 50.0% of applications are subsequently allowed. This success rate is in the 98% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 100.0% of cases where such amendments are filed. This entry rate is in the 100% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 44% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.